Global Botanical And Plant-Derived Drugs Market, By Source (Plant, Algae, Macroscopic fungi, and Others), By Dosage Form (Pills, Tablets, Capsules, and Injection), By Therapeutic Application (Central Nervous System, Cardiovascular Diseases, Infectious Diseases, and Respiratory Diseases), By Region (North America, Latin America, Europe, Middle East, Asia Pacific, Africa) - Trends, Analysis and Forecast till 2029

Report Code: PMI1818 | Publish Date: December 2023 | No. of Pages: 168

Global Botanical And PlantDerived Drugs Overview

Botanical drugs are derived from medicinal plants. These plant derived drugs are combination of botanical as well as other approved drugs that contains plant materials, synthetic and semi synthetic substances. Botanical drugs and plant derived drugs are an important component of traditional medicine and therapies, which include homeopathy and ayurvedic medicines. The major classes of plant drugs are steroids, terpenes, phenols, and glycosides. Botanical drugs are available in various forms, such as tablets, pills, capsules and injections.

Global Botanical And PlantDerived Drugs Dynamics

North America dominates the global botanical and plant-derived drugs market and is expected to maintain its dominancy over the forecast period owing to rising awareness towards botanical and plant derived drugs and increasing prevalence of diseases, in the region.

The markets in Asia Pacific and Europe are expected to show significant growth rates in global botanical and plant-derived drugs market. This can be attributed to growing technological advancement in production procedure of botanical is also supporting in the region.

Moreover, increasing number of chronic disease across the globe is a major factor driving growth of the global botanical and plant-derived drugs market.

However, stringent laws and regulations for approval of botanical drugs is a major factor expected to hamper growth of the global botanical and plant-derived drugs market over the forecast period. 

 

Access Crucial Insights at a Fraction of the Cost | Request Your Discount

Global Botanical And PlantDerived Drugs Segmentation

The global botanical and plant-derived drugs market has been segmented on the basis of source, dosage form, therapeutic application, and region. The source segment includes plant, algae, macroscopic fungi, and others. On the basis of dosage form the global botanical and plant-derived drugs market has been segmented pills, tablets, capsules, and injection. The therapeutic application segment includes central nervous system, cardiovascular diseases, infectious diseases, and respiratory diseases.

On the basis of region the target market has been segmented into North America, Europe, Asia Pacific, Latin America, Middle East and Africa. North America is expected to account major market share as compared to that of other regions.

Reduce costs by up to 30% with a custom report tailored to your specific needs | Request Customized Report

Global Botanical And PlantDerived Drugs Key Players

Key players operating in the global botanical and plant-derived drugs market includes Bayer Healthcare, GlaxoSmithKline, Pfizer,Inc., Sanofi, Actelion Pharmaceuticals, Aimil Pharmaceuticals, Allergan, AstraZeneca, Boehringer Ingelheim, and GW Pharmaceuticals.

Global Botanical And PlantDerived Drugs Table of Contents

Research Objective and Assumption

  • Preface
  • Research Objectives
  • Study Scope
  • Years Considered for the study
  • Assumptions
  • Abbreviations

Research Methodology

  • Research data
  • Primary Data
    • Primary Interviews
    • Primary Breakdown
    • Key data from Primary Sources
    • Key Thickness Insights
  • Secondary Data
    • Major Secondary Sources
    • Secondary Sources
  • Market Estimation
  • Top-Down Approach
    • Approach for estimating Market Share by Top-Down Analysis (Supply Side)
  • Bottom-Up Approach
    • Approach for estimating market share by Bottom-up Analysis (Demand Side)
  • Market Breakdown and Data Triangulation
  • Research Assumptions

Market Preview

  • Executive Summary
  • Key Findings—Global Outlook for medical carts Strategies
    • Key Questions this Study will Answer
    • Market Snippet, By Source
    • Market Snippet, By Dosage Form
    • Market Snippet, By THERAPEUTIC APPLICATION
    • Market Snippet, By Region
  • Opportunity Map Analysis
  • Executive Summary—3 Big Predictions

Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restrains
    • Market Opportunities
    • Market Trends
  • DR Impact Analysis
  • PEST Analysis
  • Porter’s Five Forces Analysis
  • Opportunity Orbit
  • Market Investment Feasibility Index
  • Macroeconomic Factor Analysis

Botanical And Plant-Derived Drugs Market, By Source, Forecast Period up to 10 Years, (US$ Bn)

  • Overview
    • Market Value and Forecast (US$ Bn), and Share Analysis (%), Forecast Period up to 10 Years
    • Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
    • Segment Trends
  • Plant
    • Overview
    • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
  • Algae
    • Overview
    • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
  • Macroscopic fungi
    • Overview
    • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
  • Others
    • Overview
    • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years

Botanical And Plant-Derived Drugs Market, By Dosage Form, Forecast Period up to 10 Years, (US$ Bn)

  • Overview
    • Market Value and Forecast (US$ Bn), and Share Analysis (%), Forecast Period up to 10 Years
    • Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
    • Segment Trends
  • Pills
    • Overview
    • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
  • Tablets
    • Overview
    • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
  • Capsules
    • Overview
    • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
  • Injection
    • Overview
    • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years

Botanical And Plant-Derived Drugs Market, By THERAPEUTIC APPLICATION, Forecast Period up to 10 Years, (US$ Bn)

  • Overview
    • Market Value and Forecast (US$ Bn), and Share Analysis (%), Forecast Period up to 10 Years
    • Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
    • Segment Trends
  • Central Nervous System 
    • Overview
    • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
  • Cardiovascular Diseases
    • Overview
    • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
  • Infectious Diseases
    • Overview
    • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
  • Respiratory Diseases 
    • Overview
    • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years

Botanical And Plant-Derived Drugs Market, By Region, Forecast Period up to 10 Years, (US$ Bn)

  • Overview
    • Market Value and Forecast (US$ Bn), and Share Analysis (%), Forecast Period up to 10 Years
    • Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
    • Regional Trends
  • North America
    • Market Size and Forecast (US$ Bn), By Source, Forecast Period up to 10 Years
    • Market Size and Forecast (US$ Bn), By Dosage Form, Forecast Period up to 10 Years
    • Market Size and Forecast (US$ Bn), By THERAPEUTIC APPLICATION, Forecast Period up to 10 Years
    • Market Size and Forecast (US$ Bn), By Country, Forecast Period up to 10 Years
      • U.S.
      • Canada
  • Europe
    • Market Size and Forecast (US$ Bn), By Source, Forecast Period up to 10 Years
    • Market Size and Forecast (US$ Bn), By Dosage Form, Forecast Period up to 10 Years
    • Market Size and Forecast (US$ Bn), By THERAPEUTIC APPLICATION, Forecast Period up to 10 Years
    • Market Size and Forecast (US$ Bn), By Country, Forecast Period up to 10 Years
      • UK
      • France
      • Germany
      • Russia
      • Italy
      • Rest of Europe
  • Asia Pacific
    • Market Size and Forecast (US$ Bn), By Source, Forecast Period up to 10 Years
    • Market Size and Forecast (US$ Bn), By Dosage Form, Forecast Period up to 10 Years
    • Market Size and Forecast (US$ Bn), By THERAPEUTIC APPLICATION, Forecast Period up to 10 Years
    • Market Size and Forecast (US$ Bn), By Country, Forecast Period up to 10 Years
      • India
      • Japan
      • South Korea
      • China
      • Rest of Asia Pacific
  • Latin America
    • Market Size and Forecast (US$ Bn), By Source, Forecast Period up to 10 Years
    • Market Size and Forecast (US$ Bn), By Dosage Form, Forecast Period up to 10 Years
    • Market Size and Forecast (US$ Bn), By THERAPEUTIC APPLICATION, Forecast Period up to 10 Years
    • Market Size and Forecast (US$ Bn), By Country, Forecast Period up to 10 Years
  • Brazil
  • Mexico
  • Rest of Latin America
  • Middle East & Africa
    • Market Size and Forecast (US$ Bn), By Source, Forecast Period up to 10 Years
    • Market Size and Forecast (US$ Bn), By Dosage Form, Forecast Period up to 10 Years
    • Market Size and Forecast (US$ Bn), By THERAPEUTIC APPLICATION, Forecast Period up to 10 Years
    • Market Size and Forecast (US$ Bn), By Country, Forecast Period up to 10 Years
  • GCC
  • Israel
  • South Africa
  • Rest of Middle East

Competitive Landscape

  • Heat Map Analysis
  • Market Presence and Specificity Analysis

Company Profiles

  • Respiratory Diseases
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • GlaxoSmithKline
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Pfizer,Inc.
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Sanofi
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Actelion Pharmaceuticals
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Aimil Pharmaceuticals
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Allergan
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • AstraZeneca
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Boehringer Ingelheim
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • GW Pharmaceuticals.
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies

The Last Word

  • Future Impact
  • About Us
  • Contact

FAQs

Global Botanical And Plant-Derived Drugs Market is segmented, By Source (Plant, Algae, Macroscopic fungi, and Others), By Dosage Form (Pills, Tablets, Capsules, and Injection), and By Therapeutic Application (Central Nervous System, Cardiovascular Diseases, Infectious Diseases, and Respiratory Diseases)

Increasing demand for effective treatment of chronic disorders coupled with new product launch are major factors driving growth of the global botanical and plant derived drugs market.

Key players operating in the global botanical and plant-derived drugs market includes Bayer Healthcare, GlaxoSmithKline, Pfizer,Inc., Sanofi, Actelion Pharmaceuticals, Aimil Pharmaceuticals, Allergan, AstraZeneca, Boehringer Ingelheim, and GW Pharmaceuticals.